CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,554,454 | -40.3% | 925,270 | +0.6% | 0.00% | – |
| Q2 2023 | $2,602,066 | -72.2% | 919,458 | -51.7% | 0.00% | -100.0% |
| Q1 2023 | $9,343,445 | -75.5% | 1,902,942 | -46.4% | 0.00% | 0.0% |
| Q4 2022 | $38,164,010 | +117.1% | 3,553,446 | +89.2% | 0.00% | 0.0% |
| Q3 2022 | $17,582,000 | -1.5% | 1,878,433 | -3.9% | 0.00% | 0.0% |
| Q2 2022 | $17,845,000 | -12.6% | 1,954,546 | +16.3% | 0.00% | 0.0% |
| Q1 2022 | $20,419,000 | +12.0% | 1,680,599 | +12.3% | 0.00% | 0.0% |
| Q4 2021 | $18,227,000 | -21.6% | 1,496,500 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $23,239,000 | +0.7% | 1,504,166 | -7.0% | 0.00% | 0.0% |
| Q2 2021 | $23,086,000 | +15.5% | 1,617,778 | +75.7% | 0.00% | 0.0% |
| Q1 2021 | $19,992,000 | +37.3% | 920,885 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $14,563,000 | +20.5% | 962,549 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $12,083,000 | -29.5% | 949,533 | -5.3% | 0.00% | 0.0% |
| Q2 2020 | $17,141,000 | +27.1% | 1,002,413 | -1.8% | 0.00% | 0.0% |
| Q1 2020 | $13,488,000 | -16.2% | 1,021,070 | +2.1% | 0.00% | 0.0% |
| Q4 2019 | $16,105,000 | -4.8% | 999,682 | +8.0% | 0.00% | 0.0% |
| Q3 2019 | $16,924,000 | -57.1% | 925,835 | -49.5% | 0.00% | -66.7% |
| Q2 2019 | $39,417,000 | +13.8% | 1,833,354 | +3.8% | 0.00% | 0.0% |
| Q1 2019 | $34,648,000 | +25.5% | 1,765,937 | -16.8% | 0.00% | 0.0% |
| Q4 2018 | $27,602,000 | -45.9% | 2,123,225 | -0.3% | 0.00% | -25.0% |
| Q3 2018 | $51,024,000 | +54.9% | 2,130,474 | +23.9% | 0.00% | +33.3% |
| Q2 2018 | $32,940,000 | +1.5% | 1,720,096 | -34.4% | 0.00% | 0.0% |
| Q1 2018 | $32,457,000 | +34.0% | 2,621,597 | +32.5% | 0.00% | +50.0% |
| Q4 2017 | $24,220,000 | -51.0% | 1,978,724 | -45.2% | 0.00% | -50.0% |
| Q3 2017 | $49,449,000 | -1.0% | 3,611,930 | +11.3% | 0.00% | 0.0% |
| Q2 2017 | $49,943,000 | +557.8% | 3,245,043 | +686.2% | 0.00% | +300.0% |
| Q1 2017 | $7,592,000 | +134.0% | 412,739 | +18.4% | 0.00% | – |
| Q4 2016 | $3,244,000 | +19.3% | 348,531 | +7.1% | 0.00% | – |
| Q3 2016 | $2,720,000 | +75.8% | 325,309 | +1.1% | 0.00% | – |
| Q2 2016 | $1,547,000 | -23.3% | 321,834 | -0.7% | 0.00% | – |
| Q1 2016 | $2,018,000 | -57.6% | 324,157 | +14.6% | 0.00% | -100.0% |
| Q4 2015 | $4,765,000 | +28.0% | 282,766 | +8.5% | 0.00% | – |
| Q3 2015 | $3,723,000 | +159.3% | 260,682 | +120.6% | 0.00% | – |
| Q2 2015 | $1,436,000 | +49.7% | 118,148 | +23.8% | 0.00% | – |
| Q1 2015 | $959,000 | -3.0% | 95,473 | -3.8% | 0.00% | – |
| Q4 2014 | $989,000 | +16.8% | 99,196 | -1.6% | 0.00% | – |
| Q3 2014 | $847,000 | -48.4% | 100,782 | +4.7% | 0.00% | – |
| Q2 2014 | $1,640,000 | +153.5% | 96,241 | +177.2% | 0.00% | – |
| Q1 2014 | $647,000 | – | 34,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |